Pantoprazol Aurobindo (Pantoprazole)

Pantoprazol Aurobindo is a proton pump inhibitor that addresses disorders linked to excess gastric acid secretion.

• Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with this rare endocrine disorder.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By binding covalently to the pump’s cysteine residues, it blocks the final step of acid production, leading to a sustained increase in gastric pH and reduced acidity in the stomach.

Pantoprazol Aurobindo may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: typically self‑limiting.
• Nausea: occasional and transient.
• Abdominal pain: mild discomfort.
• Flatulence: excess gas.
• Constipation: infrequent.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis risk.
• Acute interstitial nephritis: kidney inflammation.
• Severe hypersensitivity: rash, angio‑edema, anaphylaxis.
• Osteoporotic fractures: increased risk with long‑term use.
• Vitamin B12 deficiency: possible with prolonged therapy.
• Hepatic injury: rare elevation of liver enzymes.

Before prescribing Pantoprazol Aurobindo, clinicians should consider several safety aspects.

• Assess renal function: dose adjustment may be required in severe impairment.
• Review liver status: use with caution in hepatic disease.
• Evaluate osteoporosis risk: long‑term therapy may affect bone density.
• Monitor for infections: PPIs can increase susceptibility to gastrointestinal infections.
• Pregnancy and lactation: weigh benefits against potential risks.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazol Aurobindo can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

• Ketoconazole oral suspension: reduced absorption due to higher gastric pH.
• Atazanavir: markedly decreased plasma concentrations.
• Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR, monitor coagulation.
• Methotrexate (high dose): reduced renal clearance, watch for toxicity.
• Digoxin: slight increase in serum levels, assess clinical response.
• Iron supplements: decreased absorption, separate dosing times.